Todd M. Abbrecht, Director, is a Managing Director with Thomas H. Lee Advisors, LLC, which is the general partner of Thomas H. Lee Partners, L.P. Prior to joining Thomas H. Lee Partners in 1992, Mr. Abbrecht was in the Mergers and Acquisitions department of Credit Suisse First Boston. Mr. Abbrecht serves on the board of Simmons Company, Michael Foods, Inc., Dunkin' Brands, Inc., and ARAMARK Holdings Corporation.
Senior Vice President and Chief Financial Officer Humana, Inc.
James H. Bloem, Director, is Senior Vice President and Chief Financial Officer of Humana Inc., a position he has held since 2001. Humana is one of the nation's largest health benefit companies with over 11 million medical members. In addition, from 1996 to 2000, he served as a member of the Board of Directors of one of the Company's predecessor companies. Mr. Bloem also currently serves on the board of Rotech Healthcare, Inc.
Roger M. Boissonneault was appointed Chief Executive Officer, President and Director of Warner Chilcott as of January 5, 2005. Mr. Boissonneault was appointed Chief Executive Officer and Director for the Predecessor in September 2000. From 1996 to 2000, he served as President and Chief Operating Officer of the company acquired by the Predecessor, which was also known as Warner Chilcott PLC, serving as a director from 1998 through 2000. From 1976 to 1996, Mr. Boissonneault served in various capacities with Warner-Lambert (now a part of Pfizer), including Vice President, Female Healthcare, Director of Corporate Strategic Planning and Director of Obstetrics/Gynecology Marketing.
John Connaughton, Director, has been a Managing Director at Bain Capital Partners, LLC since 1997 and a member of the firm since 1989.
Prior to joining Bain Capital, Mr. Connaughton was a
consultant at Bain & Company, Inc. where he worked in the healthcare, consumer products and busines services industries. Mr. Connaughton
currently serves as a director of Hospital Corporation of America, AMC Theatres, M|C Communications (PriMed),
Sungard Data Systems, Warner Music Group, CRC Health Group, Cumulus Media Partners and The
Boston Celtics. He also serves as a member of the Berklee College of Music Board of Trustees and the University of Virginia McIntire Foundation Board of Trustees.
Private Investor Former Executive Chairman, Warner Chilcott PLC
John A. King, Ph.D., who became a Director of the Company in June 2005, is a private
investor. Dr. King served in positions of increasing responsibility with the Predecessor for 26 years,
most recently as Executive Chairman, a position he held from 2000 until January 5, 2005.
President and Chief Executive Officer CCMP Capital Advisors, LLC
Stephen P. Murray, Director, is the President and Chief Executive Officer of
CCMP Capital Advisors, LLC, a private equity firm formed in August 2006 when the buyout/growth
equity professionals of JPMP separated from JPMorgan Chase & Co. to form an independent private
equity platform. Mr. Murray focuses on investments in consumer and retail services; financial services;
and healthcare infrastructure. Prior to joining JPMP in 1989, Mr. Murray was a Vice President with the
Middle-Market Lending Division of Manufacturers Hanover. Currently, he serves on the board of
directors of AMC Entertainment, ARAMARK Corporation, Cabela's, CareMore Medicial Enterprises, Generac Power Systems, Jetro Holdings, MedQuest Associates,
Noble Environmental Power, Pinnacle Foods Group, Quiznos Subs and Strongwood Insurance.
Patrick J. O'Sullivan , Director, is a pharmaceutical business consultant. Prior to retirement in 2006, Mr. O'Sullivan served in positions of increasing responsibility with LEO Pharma for over 30 years, most recently as the chief executive officer of Leo Pharma Ireland and a director of Leo Pharma A/S. He also served as a director of LEO Pharmaceuticals Ltd. UK, LEO Pharma SA France and The LEO Foundation. Mr. O'Sullivan is a registered pharmacist, member and honorary fellow of the Pharmaceutical Society of Ireland and a Knight of the Order of the Dannebrog. Currently he serves on the board of directors of Chanelle Pharmaceuticals Manufacturing Ltd., as the Chairman of the Board of Trustees of the Beacon Hospital and as the Chairman of the Board of Directors and Chair of the Compensation Committee of Merrion Pharmaceuticals Plc.
Stock transaction information provided by EDGAR Online. Warner Chilcott makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
Contact the Board
You can contact Warner Chilcott plc's Board of Directors to provide comments, to report concerns, or to ask a question, at the following address.
Corporate Secretary
Warner Chilcott plc 100 Enterprise Drive Rockaway, NJ 07866 United States
You may submit your concern anonymously or confidentially by postal mail. You may also indicate whether you are a shareholder, customer, supplier, or other interested party.
Communications are distributed to the Board, or to any individual directors as appropriate, depending on the facts and circumstances outlined in the communication. In that regard, the Warner Chilcott plc board of directors has requested that certain items which are unrelated to the duties and responsibilities of the board should be excluded, such as:
Product complaints
Product inquiries
New product suggestions
Resumes and other forms of job inquiries
Surveys
Business solicitations or advertisements
In addition, material that is unduly hostile, threatening, illegal or similarly unsuitable will be excluded, with the provision that any communication that is filtered out must be made available to any non-management director upon request.
Investor Relations
= Chair
= Member
= Independent Director
